39598 Federal Register / Vol. 65, No. 124 / Tuesday, June 27, 2000 / Notices

The petitions were submitted

pursuant to section 251 of the Trade Act

of 1974 (19 U.S.C. 2341). Consequently,

the United States Department of

Commerce has initiated separate

investigations to determine whether

increased imports into the United States

of articles like or directly competitive

with those produced by each firm

contributed importantly to total or

partial separation of the firm’s workers,

or threat thereof, and to a decrease in

sales or production of each petitioning

firm.

Any party having a substantial

interest in the proceedings may request

a public hearing on the matter. A

request for a hearing must be received

by Trade Adjustment Assistance, Room

7315, Economic Development

Administration, U.S. Department of

Commerce, Washington, DC 20230, no

later than the close of business of the

tenth calendar day following the

publication of this notice.

The Catalog of Federal Domestic

Assistance official program number and title

of the program under which these petitions

are submitted is 11.313, Trade Adjustment

Assistance.

Dated: June 19, 2000.

Anthony J. Meyer,

Coordinator, Trade Adjustment and

Technical Assistance.

[FR Doc. 00–16173 Filed 6–26–00; 8:45 am]

BILLING CODE 3510–24–P

DEPARTMENT OF COMMERCE

Bureau of Export Administration

Information Systems Technical

Advisory Committee; Notice of

Partially Closed Meeting

The Information Systems Technical

Advisory Committee (ISTAC) will meet

on July 13 & 14, 2000, 9:00 a.m., in the

Herbert C. Hoover Building, Room 3884,

14th Street between Pennsylvania

Avenue and Constitution Avenue, NW.,

Washington, DC. The ISTAC advises the

Office of the Assistant Secretary for

Export Administration on technical

questions that affect the level of export

controls applicable to information

systems equipment and technology.

July 13

Public Session

1. Discussion on activities related to

development of an alternative to

Composite Theoretical Performance

(CTP)

2. Presentation on Inter-processors

communications: the Infiniband and the

Intel 870 chipset

3. Industry proposal for Commerce

Control List item 5E001

4. Additional comments or

presentations from the public

July 13 & 14

Closed Session

5. Discussion of matters properly

classified under Executive Order 12958,

dealing with U.S. export control

programs and strategic criteria related

thereto.

A limited number of seats will be

available for the public session.

Reservations are not accepted. To the

extent time permits, members of the

public may present oral statements to

the ISTAC. The public may submit

written statements at any time before or

after the meeting. However, to facilitate

distribution of public presentation

materials to Committee members, the

ISTAC suggests that public presentation

materials or comments be forwarded

before the meeting to the address listed

below: Ms. Lee Ann Carpenter, OSIES/

EA/BXA MS: 3876, U.S. Department of

Commerce, 14th St. & Constitution Ave.,

N.W., Washington, D.C. 20230.

The Assistant Secretary for

Administration, with the concurrence of

the delegate of the General Counsel,

formally determined on September 10,

1999, pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended, that the series of meetings or

portions of meetings of this Committee

and of any Subcommittees thereof

dealing with the classified materials

listed in 5 U.S.C. 552(c)(1) shall be

exempt from the provisions relating to

public meetings found in section

10(a)(1) and (a)(3), of the Federal

Advisory Committee Act. The remaining

series of meetings or portions thereof

will be open to the public.

A copy of the Notice of Determination

to close meetings or portions of

meetings of this Committee is available

for public inspection and copying in the

Central Reference and Records

Inspection Facility, Room 6020, U.S.

Department of Commerce, Washington,

D.C. For more information or copies of

the minutes call Lee Ann Carpenter,

202–482–2583.

Dated: June 21, 2000.

Lee Ann Carpenter,

Committee Liaison Officer.

[FR Doc. 00–16194 Filed 6–26–00; 8:45 am]

BILLING CODE 3510–JT–M

DEPARTMENT OF COMMERCE

International Trade Administration

[A–570–853]

Notice of Amended Final

Determination of Sales at Less Than

Fair Value: Bulk Aspirin From the

People’s Republic of China

AGENCY: Import Administration,

International Trade Administration,

Department of Commerce.

EFFECTIVE DATE: June 27, 2000.

FOR FURTHER INFORMATION CONTACT: Rosa

Jeong or Ryan Langan, Import

Administration, International Trade

Administration, U.S. Department of

Commerce, Washington, DC 20230;

telephone: (202) 482–3853 or 482–1279,

respectively.

SUPPLEMENTARY INFORMATION:

The Applicable Statute and Regulations

Unless otherwise indicated, all

citations to the statute are references to

provisions of the Tariff Act of 1930

(‘‘the Act’’) as amended by the Uruguay

Round Agreements Act (‘‘URAA’’). In

addition, unless otherwise indicated, all

citations to the Department of

Commerce’s (‘‘the Department’s’’)

regulations refer to 19 CFR part 351

(April 1999).

Scope of Investigation

The product covered by this

investigation is bulk acetylsalicylic acid,

commonly referred to as bulk aspirin,

whether or not in pharmaceutical or

compound form, not put up in dosage

form (tablet, capsule, powders or similar

form for direct human consumption).

Bulk aspirin may be imported in two

forms, as pure ortho-acetylsalicylic acid

or as mixed ortho-acetylsalicylic acid.

Pure ortho-acetylsalicyclic acid can be

either in crystal form or granulated into

a fine powder (pharmaceutical form).

This product has the chemical formula

C9H8O4. It is defined by the official

monograph of the United States

Pharmacopoeia (‘‘USP’’) 23. It is

classified under the Harmonized Tariff

Schedule of the United States

(‘‘HTSUS’’) subheading 2918.22.1000.

Mixed ortho-acetylsalicylic acid

consists of ortho-acetylsalicylic acid

combined with other inactive

substances such as starch, lactose,

cellulose, or coloring materials and/or

other active substances. The presence of

other active substances must be in

concentrations less than that specified

for particular nonprescription drug

combinations of aspirin and active

substances as published in the

Handbook of Nonprescription Drugs,